Skip to Content

Maryam Shariati

Advisor: Funda Meric-Bernstam, Ph.D.

GSBS Start Date: Fall 2013

Education & Training

B.S. in Cell and Developmental Biology from the University of California Irvine, Irvine, CA, 2009 Cancer Biology from The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, 2012

Research Info

Targeted therapy of HR-positive HER2-negative breast cancer, PIK3CA and AKT1genomic aberrations, Resistant mechanism to CDK4/6 inhibitors, Synthetic lethality screening, Therapeutic targeting of discoidin domain receptor 1 (DDR1), Combinational inhibition of AKT1 and BCL2, Acquired ESR1 mutations, Endocrine therapy resistance